|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.650 HKD | -1.49% |
|
-3.28% | -41.63% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 832.8 | - | - |
| Change | - | -30.05% | -30.06% | -43.82% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 901.5 | 832.8 | 671.1 |
| Change | - | -16.83% | -28.53% | -38.62% | -7.62% | -19.42% |
| P/E | -1.04x | -4.72x | -3.96x | -5x | 17.6x | 2.21x |
| PBR | 2.25x | 2.17x | 1.52x | 1.81x | 1.64x | 1.19x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 1.29x | 0.71x | 0.48x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.4x | 0.71x | 0.39x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -7.59x | 10.2x | 1.51x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -6.29x | 15.8x | 2.75x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -2.94x | -29.5x | 10.9x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -34% | -3.39% | 9.19% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 2.292 | 2.292 | 2.292 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 3/27/24 A | 3/24/25 A | 3/24/26 A | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5x | 1.4x | -7.59x | - | 123M | |
| 34.92x | 12.63x | 25.81x | 0.57% | 1,060B | |
| 27.42x | 6.3x | 17.1x | 2.08% | 619B | |
| 30x | 7.34x | 15.02x | 2.76% | 438B | |
| 17.98x | 4.45x | 11.01x | 2.97% | 333B | |
| 21.52x | 5.52x | 13.36x | 2.86% | 282B | |
| 21.56x | 4.53x | 12.65x | 1.94% | 267B | |
| 14.17x | 5.3x | 10.9x | 3.52% | 218B | |
| 23.77x | 6.31x | 11.12x | 2.78% | 196B | |
| -46.02x | 5.6x | 31.12x | 2.5% | 161B | |
| Average | 14.03x | 5.94x | 14.05x | 2.44% | 357.4B | |
| Weighted average by Cap. | 23.86x | 7.85x | 18.16x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
